The enteral feeding device is a healthcare device that provides nutrition to persons who are unable to eat by mouth, are unable to swallow carefully, or require nutritional supplementation. Furthermore, enteral feeding refers to food consumption through the gastrointestinal (GI) system. The digestive tract comprises the mouth, stomach, esophagus, and intestines. Enteral feeding devices are medical devices that are used to administer drugs and nutrients to people with chronic conditions such as cancer, gastrointestinal disorders, malnutrition, and others. They can receive nutrition and keep their GI tract functional by feeding through a tube. The enteral feeding devices market value in 2021 was $3.48 billion, and it will be worth $6.088 billion by 2030 at a 6.38% CAGR during 2021-2030.
COVID-19 Impact
The global impact of COVID-19 has grown at an accelerating rate. Enteral feeding devices have required improvements in patient care and provide additional nutritional support to Covid-Virus patients. During the pandemic period, the demand for enteral feeding equipment such as feeding tubes and administration sets surged, driving the market growth. The National Nurses Nutrition Group has also established guidelines for patients and healthcare workers that provide nutritional support for the patient.
Key Industry Drivers
Rise In the geriatric population
The world population is predicted to age, and the prevalence of disorders that primarily affect the elderly is expected to rise. The world’s population is aging rapidly, with a steady increase in the population aged 60 and up. Disease prevalence is driving the expansion of the market. Because of the need for therapy supported by enteral feeding devices, the increasing demand from patients who rely on feeding devices is likely to boost the enteral feeding devices market.
Increased availability of home enteral nutrition
The enteral feeding device industry has switched from hospital to home enteral nutrition, and this trend is projected to continue. Because hospital stays are becoming increasingly expensive, experts involved in caring for patients who require nutritional assistance for extended periods are urging patients to select home enteral nutrition. The growth of the home enteral nutrition business is having a substantial impact on the enteral feeding equipment market.
Restraining Factors
Enteral feeding is a rapid and low-cost method of providing therapeutic nutrients to patients. However, there are a few downsides to employing these gadgets, which result in greater healthcare costs. Most enteral feeding problems are minor, although they can be rather serious. Despite their lower frequency and severity, enteral feeding metabolic issues are similar to parenteral nutrition. Close monitoring can help to reduce or prevent these difficulties. Furthermore, these difficulties, together with the associated mortality, provide a barrier to the widespread use of enteral feeding devices.
Key Opportunities
Because of its high-quality and various healthcare markets, expanding prevalence of R&D initiatives for creating innovative feeding technologies, and ongoing rise in chronic disorders and infectious diseases, the APAC area is expected to offer enormous growth prospects in the future. Furthermore, the ability to manufacture feeding devices at a cheaper cost would encourage key market participants to spend intelligently on enteral feeding devices in this region in the future.
Product Insights
In 2021, the enteral feeding pump segment had more than 40.0% revenue share. Enteral-based feeding or nutrition is frequent for the pediatric and adult population with chronic diseases to promote nutrient uptake and prevent malnutrition. These disorders restrict oral nutrition intake, which further drives the segment. The increased acceptance of such devices for home care and hospital use, as they are safe and administer adequate nutrition, might also be attributed to the rise of this market. Furthermore, the introduction of technologically improved equipment accelerates the market growth.
Because of the increased popularity of low-profile gastronomy devices in the pediatric and geriatric populations, the low-profile gastronomy device sector will grow at the fastest CAGR of 6.0% during the projected period. Compact designs and attractive looks are some of the factors driving market expansion.
Regional Insights
In 2021, North America had the highest share of revenue, more than 35.0%. The presence of a high senior population dealing with chronic ailments can be ascribed to the regional market’s rise. As per data given by the Centers for Disease Control and Prevention, 85% of the older population has at least one chronic disease, and 60% has at least two chronic diseases.
Furthermore, the increasing prevalence of cancer, Alzheimer’s disease, and other lifestyle illnesses drive demand for enteral feeding devices. Increasing knowledge of the usage of enteral feeding systems, the rising need for radiation operations and reconstructive surgeries, and successful reimbursement policies are only a few of the major factors driving regional demand.
Key Players
Cook Group, Abbott Laboratories, Cardinal Health, Inc., Boston Scientific Corporation, CONMED Corporation, Becton, Dickinson and Company, B. Braun Melsungen AG, Fresenius SE & Co. Moog, Inc., Vygon S.A, Dynarex Corporation, Amsino International Inc., Applied Medical Technology, Inc., Medela AG, and KGaA are significant market participants in the global enteral feeding devices market.
